Lab Safety: Regulating Gain-of-Function
The United States government has taken a significant step toward securing high-stakes biological research. In response to years of debate regarding the origins of pandemics and the safety of laboratory environments, the White House Office of Science and Technology Policy (OSTP) released a robust new policy in May 2024. This framework creates stricter oversight for research that involves enhancing potential pandemic pathogens, commonly known as “gain-of-function” research.
The New Unified Policy for Biosecurity
For years, the scientific community operated under a patchwork of guidelines that many experts argued were insufficient for modern biological risks. The new document, titled the “United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential,” marks a pivotal shift in how the U.S. manages high-risk virology.
This policy replaces two older frameworks: the 2012 policy regarding “Dual Use Research of Concern” (DURC) and the 2017 framework known as P3CO (Potential Pandemic Pathogen Care and Oversight). By merging these into a single, comprehensive directive, the government aims to close loopholes that previously allowed certain risky experiments to proceed without high-level federal review.
Moving Beyond the “List” Approach
One of the most critical changes in the 2024 policy is the move away from a static list of dangerous agents. Previously, regulations focused heavily on a specific set of known pathogens, such as Anthrax, Ebola, or Avian Influenza. If a researcher was working with a virus that was not on that list, they faced fewer regulatory hurdles, even if the research was dangerous.
The new policy focuses on the properties of the biological agent rather than its name. It applies to any research involving biological agents that are likely to be highly transmissible and virulent in humans. This means if a scientist plans to modify a relatively harmless virus in a way that could make it deadly and contagious, that experiment now falls under strict federal oversight, regardless of the virus’s name.
Understanding Gain-of-Function Research
To understand the impact of these regulations, it is necessary to understand what “gain-of-function” actually entails. In the context of virology, this term refers to experiments where a natural pathogen is altered in a laboratory to give it new abilities.
Why Scientists Perform These Experiments
Despite the risks, this research has historically been defended by major institutions like the National Institutes of Health (NIH). The primary arguments for continuing this work include:
- Predicting Evolution: Scientists modify viruses to see how they might naturally evolve in the wild. This helps them anticipate future mutations that could cause outbreaks.
- Testing Vaccines: By creating a more dangerous version of a virus in a lab, researchers can test if current vaccines and treatments would hold up against a “worst-case scenario” strain.
The Risks Involved
The controversy arises from the potential for a “lab leak.” If a pathogen is enhanced to be more contagious or deadly and then accidentally escapes the facility, it could spark a man-made pandemic. The new White House policy explicitly aims to mitigate this risk by requiring a more rigorous risk-benefit analysis before any funding is granted.
The Implementation Timeline and Compliance
The White House has set a clear clock for implementation. Federal funding agencies and research institutions have been given one year from the May 2024 announcement to bring their protocols into compliance. This puts the effective date around May 2025.
During this transition period, universities and private labs receiving federal money must establish or update their internal review entities. These local committees are the first line of defense. They are responsible for identifying proposed research that fits the new definition of “Dual Use Research of Concern” and reporting it to federal funding agencies.
Institutional Responsibility
The burden of safety is being placed heavily on the institutions themselves. Under the new rules, universities must verify that they have the physical infrastructure to contain these pathogens. Furthermore, they must provide ongoing training for all personnel involved. If an institution fails to comply with these oversight requirements, they risk losing all federal funding—a penalty that could amount to hundreds of millions of dollars for major research universities.
Closing Loopholes in Oversight
Critics of the previous 2017 P3CO framework often pointed out that it was too narrow. It only covered research that was “reasonably anticipated” to create a pandemic strain. This vague language allowed researchers to argue that their work did not meet the threshold for review.
The new policy broadens the scope significantly. It covers any research that is “reasonably anticipated to result in” a potential pandemic pathogen. While the language sounds similar, the guidance documents provided by the OSTP clarify that the intent is to capture a wider net of experiments.
Additionally, the policy addresses “Dual Use Research.” This refers to legitimate scientific work that could be misused by bad actors to cause harm. For example, publishing the genetic code of a reconstructed devastating virus could be helpful for scientists but dangerous if used by bioterrorists. The new guidelines require a mitigation plan for how such data is shared and published.
The Role of Funding Agencies
Agencies like the NIH and the Centers for Disease Control and Prevention (CDC) are now required to be more proactive. They cannot simply rely on the checkboxes marked by the researchers applying for grants.
Under the new system, the funding agency must conduct an independent assessment of the proposed work. If they determine the research poses a severe biosecurity threat, they must ensure the benefits justify the risks. If the risks are deemed too high, or if there is a safer way to achieve the same scientific goals, the government is mandated to deny funding or require the experiment to be redesigned.
Frequently Asked Questions
What defines a “potential pandemic pathogen” under the new rules? A potential pandemic pathogen is defined as an agent that is likely to be highly transmissible and widely uncontrollable in human populations, and likely to cause significant morbidity or mortality.
Does this policy ban gain-of-function research entirely? No. The policy does not ban the research. Instead, it adds layers of scrutiny. Research can still proceed if it is proven to be critical for public health and if the safety protocols are deemed sufficient to mitigate the risks.
Who enforces these new rules? The enforcement is tied to funding. Federal agencies like the NIH, CDC, and the Department of Defense are responsible for overseeing the grants they issue. Institutions that fail to follow the rules lose their eligibility for federal money.
When do these new regulations take full effect? The policy was released in May 2024, and institutions have a one-year implementation period. Full compliance is expected by May 2025.
Does this apply to private research labs? Technically, the policy applies to research funded by the U.S. government. However, most major private labs and universities rely on federal grants, meaning they must comply with these standards to maintain their funding streams.